...
首页> 外文期刊>Biomaterials >PEGylated carboxymethyl chitosan/calcium phosphate hybrid anionic nanoparticles mediated hTERT siRNA delivery for anticancer therapy
【24h】

PEGylated carboxymethyl chitosan/calcium phosphate hybrid anionic nanoparticles mediated hTERT siRNA delivery for anticancer therapy

机译:聚乙二醇化羧甲基壳聚糖/磷酸钙杂化阴离子纳米粒子介导的hTERT siRNA递送用于抗癌治疗

获取原文
获取原文并翻译 | 示例
           

摘要

Lack of safe and effective delivery vehicle is the main obstacle for siRNA mediated cancer therapy. In this study, we synthesized a pH-sensitive polymer of PEG grafted carboxymethyl chitosan (PEG-CMCS) and developed anionic-charged hybrid nanoparticles of PEG-CMCS and calcium phosphate (Cap) for siRNA delivery through a single-step self-assembly method in aqueous condition. The formed nanoparticles with charge of around -8.25 mv and average diameter of 102.1 nm exhibited efficient siRNA encapsulation and enhanced colloidal and serum stability. The test in vitro indicated that the nanoparticles entered into HepG2 cells by endocytosis, and achieved endosomal escape of siRNA effectively due to the pH-responsive disassembly of nanoparticles and dissolution of CaP in the endosome. Reporter gene silencing assay showed that luciferase siRNA delivered by the anionic nanoparticles could achieve gene silencing efficacy comparable to that of conventional Lipofectamine 2000. Additionally, dramatic hTERT knockdown mediated by the anionic nanoparticles transfection induced significant apoptosis of HepG2 cells in vitro. After intravenous injection in tumor-bearing BALB/c nude mice, the nanopartides specifically accumulated into tumor regions by EPR effect, leading to efficient and specific gene silencing sequentially. Most importantly, the nanoparticles carrying hTERT siRNA inhibited tumor growth significantly via silencing hTERT expression and inducing cells apoptosis in HepG2 tumor xenograft. Moreover, comprehensive safety studies of the nanoparticles confirmed their superior safety both in vitro and in vivo. We concluded that the PEG-CMCS/CaP hybrid anionic nanoparticles possessed potential as a safe and effective siRNA delivery system for anticancer therapy. (C) 2014 Elsevier Ltd. All rights reserved.
机译:缺乏安全有效的运载工具是siRNA介导的癌症治疗的主要障碍。在这项研究中,我们合成了pH敏感的PEG接枝的羧甲基壳聚糖(PEG-CMCS)聚合物,并开发了PEG-CMCS和磷酸钙(Cap)的带负电荷的杂化纳米颗粒,用于通过单步自组装方法传递siRNA。在水性条件下。所形成的纳米颗粒的电荷约为-8.25 mv,平均直径为102.1 nm,显示出有效的siRNA包封以及增强的胶体和血清稳定性。体外测试表明,纳米颗粒通过内吞作用进入HepG2细胞,并且由于纳米颗粒的pH响应分解和CaP在内体中的溶解而有效地实现了siRNA的内体逃逸。记者基因沉默检测表明,阴离子纳米颗粒递送的萤光素酶siRNA可以达到与传统Lipofectamine 2000相当的基因沉默效果。此外,阴离子纳米颗粒转染介导的hTERT显着降低在体外诱导了HepG2细胞的显着凋亡。在荷瘤的BALB / c裸鼠中静脉注射后,纳米颗粒通过EPR特异地积聚到肿瘤区域,从而导致有效且特异性的基因沉默。最重要的是,携带hTERT siRNA的纳米颗粒通过沉默hTERT表达并诱导HepG2肿瘤异种移植物中的细胞凋亡而显着抑制肿瘤生长。此外,对纳米颗粒的全面安全性研究证实了它们在体外和体内的优越安全性。我们得出的结论是,PEG-CMCS / CaP杂化阴离子纳米颗粒具有作为抗癌治疗的安全有效的siRNA递送系统的潜力。 (C)2014 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号